We Can Now Customize Cancer Cures, Tumor by Tumor

But can any company afford to manufacture one-off medical treatments?

MIT Technology Review
Oct 17, 2018 · 11 min read
A blood vessel formation providing cancer cells (whose nuclei are shown in blue) with oxygens and nutrients. Illustration: Alfred Pasieka/Science Library/Getty Images

By Adam Piore

The first time someone pitched Genentech’s senior leadership on a personalized cancer vaccine, it did not go well. “I thought there was going to be a riot,” Ira Mellman, then Genentech’s head of research oncology, recalls.

You’ll also discover more fresh thinking personalized to your interests and can follow your favorite authors, publications, and topics.
Open in app
Or, continue in mobile web
Already have an account? Sign in

Learn more.

Medium is an open platform where 170 million readers come to find insightful and dynamic thinking. Here, expert and undiscovered voices alike dive into the heart of any topic and bring new ideas to the surface. Learn more

Make Medium yours.

Follow the writers, publications, and topics that matter to you, and you’ll see them on your homepage and in your inbox. Explore

Share your thinking.

If you have a story to tell, knowledge to share, or a perspective to offer — welcome home. It’s easy and free to post your thinking on any topic. Write on Medium

About

Help

Legal

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store